FTC sues Hims & Hers, alleging it shared health data with Meta, Snap
Telehealth platform disclosed users "most private" health info and locked consumers into subscriptions, regulators allege.…
27,640$
2,22%
Echtzeit-Aktienkurs Hims & Hers Health
Bid:
Ask:
Nachrichten zur Hims & Hers Health Aktie
FTC sues Hims & Hers, alleging it shared peoples health data with Meta and Snap
Telehealth platform disclosed users "most private" health info and locked consumers into subscriptions, regulators allege.…
FTC sues Hims & Hers for allegedly sharing patient information with third-party platforms
Popular telehealth provider Hims & Hers "shared consumers’ sensitive health information with third-party advertising platforms such as Meta and Snap…
Hims & Hers May Face FTC Lawsuit for Allegedly Sharing Sensitive User Data With Advertisers: Report
The FTC is suing Hims & Hers for allegedly sharing user health data with advertisers and engaging in deceptive billing…
Hims & Hers May Face FTC Lawsuit for Allegedly Sharing Sensitive User Data With Advertisers: Report
The U.S. Federal Trade Commission (FTC) is reportedly launching a major lawsuit against Hims & Hers Health Inc. www.benzinga.com/quote/HIMS(NYSE:HIMS), claiming…
FTC sues Hims & Hers over sharing user health data with Meta, Snap
The FTC is suing Hims & Hers for allegedly sharing users’ sensitive health data with advertising companies Meta Platforms and…
Hims & Hers stock sinks after FTC sues over health data sharing and billing
The agency alleges the telehealth company shared sensitive health data with Meta and Snap while deceiving users about charges and…
FTC sues Hims & Hers over health data sharing, billing
The agency alleges the telehealth company shared sensitive health data with Meta and Snap while deceiving users about charges and…
Hims misled consumers and violated their privacy, FTC alleges in a lawsuit
The U.S. Federal Trade Commission sued telehealth company Hims & Hers alleging business practices that agency says mislead consumers.…
Utah joins federal lawsuit against telehealth company Hims & Hers over data privacy concerns
Utah has joined a federal lawsuit against telehealth company Hims & Hers alleging that the company charged consumers without consent…
Update: FTC Suing Hims & Hers for Allegedly Sharing User Data With Meta, Snap
(Updates with Hims official statement in the third paragraph.) Hims & Hers Health (HIMS) is bein…
Why Is HIMS Stock Down 13% Today?
Hims & Hers (HIMS) shares slumped 13% on Wednesday after the U.S. Federal Trade Commission sued the telehealth company over…
Hims and Hers shares fall 10% as FTC sues company over data, billing practices
The FTC sued Hims & Hers over alleged health data sharing with Meta and Snap, billing practices and subscription cancellations.…
FTC sues Hims & Hers for sharing sensitive user health data with Meta and Snap
According to the FTC, Hims & Hers led customers to believe their health information was private, yet allegedly transmitted it…
Hims & Hers Health, Inc. (HIMS) Stock Drops Despite Market Gains: Important Facts to Note
In the most recent trading session, Hims & Hers Health, Inc. (HIMS) closed at $29.32, indicating a -3.04% shift from…
BlackRock (NYSE: BLK) discloses 11.9% beneficial stake in Hims & Hers (HIMS)
BlackRock reports beneficial ownership of 26,496,218 Hims & Hers Class A shares, equal to 11.9% of the class, with sole…
Hims & Hers Health shares drop almost 5% after extended selling pressure and lack of fresh catalysts
Hims & Hers Health slides 4.66% today to $28.83 as selling pressure intensifies, with shares lingering near their session lows.…
Hims & Hers Tokenized Stock price today, HIMSx to USD chart, marketcap and volume
Hims & Hers Tokenized Stock (xStock), trading under the ticker HIMSx, is a blockchain-based tokenized representation of Hims & Hers…
Will Hims & Hers Health stock break $31.91 resistance as intraday buyers stay active?
Hims & Hers Health trades at $30.24 after rising 7.65% today, showing high volatility but still below key moving averages.…
Understanding The AI Flywheel At Hims And Hers
Hims & Hers is a subscriber-based online healthcare provider that operates outside of the traditional paradigm. Learn why HIMS stock…
Hims & Hers leverages AI and vertical integration to disrupt telehealth with strong growth prospects through 2030.
Hims & Hers Health, Inc. is an innovative telehealth company that uses AI-driven processes and comprehensive patient data to create…
Hims & Hers Health Stock (HIMS) Opinions on FDA Peptide Decisions
FDA Peptide Ruling: Recent regulatory developments have dominated conversations around Hims & Hers Health, with an FDA advisory committee vote…
FDA Panel Narrowly Backs Four Peptides — Hims & Hers Stock in the Spotlight
Hims & Hers Health Inc. is in the spotlight Friday after an FDA advisory panel voted Thursday to recommend four…
Hims & Hers Health (HIMS) Draws FDA Peptide Focus, Is The Stock Undervalued?
The latest FDA advisory panel vote on broader peptide compounding access, including BPC-157 and related compounds, has pushed Hims &…
Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know
A number of stocks fell in the morning session after concerns grew over a rising number of uninsured patients. The…
HIMS Stock Sinks as FDA Gives Hims & Hers Peptide the Cold Shoulder
Hims & Hers shares crash as FDA panel votes against emideltide’s addition to the 503A Bulks List. Here’s what the…
HIMS Stock Sinks as FDA Gives Hims & Hers Peptide the Cold Shoulder
Hims & Hers shares crash as FDA panel votes against emideltide’s addition to the 503A Bulks List. Here’s what the…
Hims & Hers (HIMS) Stock Looks Cheap On Cash Flow But Pricey After A 313% Run
Hims & Hers Health stock has delivered a very large 5 year gain, yet the latest valuation work suggests the…
HIMS Maintains by Truist Securities -- Price Target Raised to $27
Hims & Hers Health Inc (HIMS) Analyst Rating Update On July 24, 2026, Truist Securities announced it…
Hims & Hers Health (HIMS) Shares Fall After FDA Panels Negative Vote on Emideltide
On July 24, 2026, Hims & Hers Health (HIMS) experienced a decline of over 11% following an unfavorable decision from…
Hims & Hers down as FDA advisors snub first peptide
Hims & Hers (HIMS) stock slides after an FDA advisory panel for the first time in a two-day meeting declines…
HIMS Stock Falls Over 10% Amid Market Fluctuations
On July 24, 2026, Hims & Hers Health Inc (HIMS) experienced a notable decline in its stock price, dropping by…
Hims & Hers Health Slides as Traders Fade Peptide Rally
Hims & Hers Health, Inc. (HIMS) is down 10.4% today. Here is some analysis on what might have caused this…
Hims & Hers: Peptide Ruling A Positive, Operational Good Sense Makes Buy Case (Upgrade)
Hims & Hers stock is upgraded to "Buy" given its upside potential. Heres what investors need to know.…
Hims & Hers falls -10.3%
Hims & Hers (HIMS) is down -10.3%, or -$3.38 to $29.36. Published first on TheFly – the ultimate source for…
Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the morning session after concerns grew over a rising number of uninsured…
Hims & Hers Health, Repligen, West Pharmaceutical Services, and 10x Genomics Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the morning session after concerns grew over a rising number of uninsured…
Hims & Hers – Ich traue einer 8-zu-6-Mehrheit keine 2,2 Mrd. USD zu!
Ich halte die Euphorie um Hims & Hers für verfrüht. Acht Ja-Stimmen gegen sechs Nein-Stimmen bei einer Enthaltung – mit…
Hims & Hers – Der US-Telemedizinanbieter reitet auf einer knappen FDA-Empfehlung!
Eine 8-zu-6-Empfehlung ist keine Zulassung. Die FDA-Berater öffnen Peptide wie BPC-157 für die Apothekenherstellung, doch die Behörde muss erst ein…
Is Trending Stock Hims & Hers Health, Inc. (HIMS) a Buy Now?
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the…
FDA Panel Narrowly Backs Four Peptides — Hims & Hers Stock in the Spotlight - Hims & Hers Health (NYSE:HI
Hims & Hers Health is in focus Friday after an FDA advisory panel on Thursday recommended adding four peptides to…
Peptide catalyst lift for Hims & Hers (NYSE:HIMS) limited by FDA review timetable
Peptide catalyst lift for Hims & Hers (NYSE:HIMS) limited by FDA review timetable - TechStock²…
Telehealth firms urge FDA to legalize peptides, with guardrails
Telehealth companies including Hims & Hers Health Inc. and Noom Inc. urged a panel of experts to recommend legalizing several…
Does FDA Peptide Shift and CAO Exit Reframe the Bull Case for Hims & Hers Health (HIMS)?
Earlier in July 2026, Hims & Hers Health announced that Chief Accounting Officer and Principal Accounting Officer Irene Becklund will…